Non-pharmacological pain care with supportive trial evidence is underused in people with inflammatory arthritis, while long-term opioids and gabapentinoids are commonly prescribed despite absent trial evidence for efficacy.
The guideline highlights that UK electronic health record data show long-term opioid and gabapentinoid prescribing is common in people with inflammatory arthritis, despite a lack of trial evidence supporting their efficacy. Patient survey data indicate that non-pharmacological pain management approaches with supportive trial evidence are underutilized.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Non-pharmacological pain care with supportive trial evidence is underused in people with inflammatory arthritis, while long-term opioids and gabapentinoids are commonly prescribed despite absent trial evidence for efficacy. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Non-pharmacological pain care with supportive trial evidence is underused in people with inflammatory arthritis, while long-term opioids and gabapentinoids are commonly prescribed despite absent trial evidence for efficacy.
This conclusion is most relevant to: People with inflammatory arthritis (IA) in the UK.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸The 2026 British Society for Rheumatology guideline for pain management in people with inflammatory arthritis. (Rheumatology (Oxford, England), 2026) —
How It Works
The proposed biological pathway:
- ▸Electronic health record data analyzed for prescribing patterns
- ▸Patient survey data assessed use of non-pharmacological care
- ▸Comparison made between pharmacological and non-pharmacological approaches
- ▸Result: Opioids/gabapentinoids commonly prescribed despite no trial evidence; non-pharmacological care underused
Who Might Benefit
Evidence fit by population:
- ▸People with inflammatory arthritis (IA) in the UK
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Abstract does not provide specific effect sizes or statistical details from the data analyses
- ▸The claim is based on observational data (electronic health records and surveys) rather than a controlled trial
Frequently Asked Questions
What types of non-pharmacological pain care are recommended for inflammatory arthritis?▼
The guideline recommends exercise and physical activity, psychological interventions, ergonomic and orthotic interventions, education, weight management and diet, addressing sleep problems, fatigue management, digital technologies, and complementary therapies.
Why are opioids and gabapentinoids still prescribed despite lack of evidence?▼
The abstract does not explain the reasons, but common factors may include clinician habit, patient demand, or lack of access to non-pharmacological alternatives.
Is this guideline specific to adults or does it include children?▼
It is a comprehensive life-course guideline that includes both paediatric and adult rheumatology perspectives.
How many recommendations does the guideline provide?▼
The guideline developed 23 recommendations covering pain assessment and various treatment modalities.
References
- 1.Scott IC, Smith TM, Babatunde O, Barker C, Battista S, Beesley R, Beesley R, Birkinshaw H, Brooke M, Chaplin H, Chapman L, Ciurtin C, Dale J, Dockrell D, Dures E, Harrison K, Holt S, Jani M, McCarron M, Mallen CD, O'Connor A, Pidgeon C, Pratt D, Prior Y, Raza K, Rutter-Locher Z, Sharma S, Shaw K, Tsigarides J, Xenophontos M, Shenker NG. “The 2026 British Society for Rheumatology guideline for pain management in people with inflammatory arthritis..” Rheumatology (Oxford, England), 2026. PMID: 42476581 DOI: 10.1093/rheumatology/keag320